Country: South Africa
Language: English
Source: South African Health Products Regulatory Authority (SAHPRA)
Lennon
PERILAX TABLETS SCHEDULING STATUS: Not Scheduled PROPRIETARY NAME (and dosage form): PERILAX TABLETS COMPOSITION: Each tablet contains: Bisacodyl 5,0 mg PHARMACOLOGICAL CLASSIFICATION: A 11.5 Medicines acting on the gastro-intestinal tract: Laxatives. PHARMACOLOGICAL ACTION: Promotes bowel movement by one or more direct actions on the intestine. INDICATIONS: Perilax is indicated for the treatment of occasional constipation, for use as bowel cleansing regimen, preparing the patient for surgery or for preparing the colon for x-ray or endoscopic examination. CONTRA-INDICATIONS: Hypersensitivity to the ingredients. Intestinal obstruction or with undiagnosed abdominal symptoms. WARNINGS: This medicine should not be used in the presence of abdominal pain, nausea or vomiting. Frequent or prolonged use of Perilax may result in dependence on laxatives and loss of normal bowel function. If you have noticed a sudden change in bowel habits that has persisted for a period of greater than 2 weeks, consult a doctor before using the laxative. The use of any laxative beyond 1 week is not recommended except on the advice of a doctor. Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition. Discontinue use and consult a doctor. Do not use this product for bowel cleansing unless directed by a doctor. DOSAGE AND DIRECTIONS FOR USE: This product generally produces bowel movement in 6 to 12 hours. Do not chew the tablets Do not give to children under 6 years of age or to persons who cannot swallow without chewing unless directed by a doctor. Do not take this product within one hour after taking an antacid or milk. Adults and children 12 years and over: One to three tablets in a single daily dose. Children 6 to under 12 years: One table Read the complete document